In vitro inhibition of Na+,K+-ATPase activity from rat cerebral cortex by guanidino compounds accumulating in hyperargininemia

Brain Research

Volumn 838, Issue 1-2, 1999, Pages 78-84

  Da Silva, Cleide Gonçalves ^a   Parolo, Edino ^a   Streck, Emílio Luiz ^a   Wajner, Moacir ^a   Wannmacher, Clóvis Milton Duval ^a   De Souza Wyse, Angela Terezinha ^a  

^a U   (Brazil)

Author keywords

Argininic acid; Guanidino compound; Homoarginine; Hyperargininemia; K+ ATPase; N Acetylarginine; Na+

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ARGINASE; ARGININE; ARGININIC ACID; GUANIDINE DERIVATIVE; HOMOARGININE; N ACETYLARGININE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; BIOACCUMULATION; CLINICAL FEATURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; ENZYME ACTIVITY; ENZYME REPRESSION; EPILEPTOGENESIS; INBORN ERROR OF METABOLISM; NERVE CELL MEMBRANE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SEIZURE;

ANIMALS; ARGININE; CEREBRAL CORTEX; ENZYME INHIBITORS; GUANIDINES; NA(+)-K(+)-EXCHANGING ATPASE; RATS; RATS, WISTAR;

EID: 0033554175     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01671-6     Document Type: Article

References (52)

1. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 14:1985;375-403.
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-die binding. Anal. Biochem. 72:1976;248-254.
3. +2-stimulated ATPase activity. Anal. Biochem. 157:1986;375-380.
4. Chevillard C., Cárdenas M.L., Cornish-Bowden A. The competition plot: a simple test of whether two reactions occur at the same active site. Biochem. J. 289:1993;599-604.
5. Choi D.W., Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13:1990;171-182.
6. J.P. Colombo, Argininaemia: clinical and biochemical aspects, in: P.P. de Deyn, I.A. Marescau, S.D. Quereshi, A. Mori (Eds.), Guanidines Compounds in Biology and Medicine, Vol. 1, John Libbey & Co., Guildford, UK, 1992, pp. 343-347.
7. Cousin M.A., Nicholls D.G., Pocock J.M. Modulation of ion gradients and glutamate release in cultured cerebellar granule cells by ouabain. J. Neurochem. 64:1995;2097-2104.
8. de Deyn P.P., Marescau B., Lornoy W., Becaus I., Lowenthal A. Guanidino compounds in uraemic dialysed patients. Clin. Chim. Acta. 157:1986;143-150.
9. de Deyn P.P., Macdonalds R.L. Guanidino compounds that are increased in uremic patients inhibit GABA- and glycine-responses on mouse neurons in cell culture. Ann. Neurol. 28:1990;627-633.
10. de Deyn P.P., Marescau B., Macdonald R.L. Guanidino compounds that are increased in hyperargininemia inhibit GABA and glycine responses on mouse neurons in cell culture. Epilepsy Res. 8:1991;134-141.
11. de Deyn P.P., D'Hooge R., Marescau B., Pei Y.Q. Chemical models of epilepsy and their applicability in the development of anticonvulsants. Epilepsy Res. 12:1992;87-110.
12. P.P. de Deyn, B. Marescau, I.A. Qureshi, S.D. Cederbaum, M. Lambert, R. Cerone, N. Chamoles, N. Spécola, J.V. Leonard, R. Gatti, Green, S.S. Kang, N. Mizutani, I. Rezvani, S.E. Snyderman, H.G. Terheggen, M. Yoshino, B. Appel, J.J. Martin, Roth, A.L. Beaudet, L. Vilarinho, E. Hirrsch, K. Jakobs, M.S. van der Knaap, H. Naito, B.A. Pickut, S.K. Shapira, A. Fuchshuber, B. Roth, K. Hylan, Hyperargininemia: a treatable inborn error of metabolism? in: P.P. de Deyn, I.A. Marescau, S.D. Qureshi, A. Mori (Eds.), Guanidino Compounds in Biology and Medicine, Vol. 2, John Libbey & Co., Guildford, UK, 1997, pp. 53-69.
13. D'Hooge R., Manil J., Colin F., de Deyn P.P. Guanidinosuccinic acid inhibits excitatory synaptic transmission in CA1 region of rat hippocampal slices. Ann. Neurol. 30:1991;622-623.
14. D'Hooge R., Pei R., Manil J., de Deyn P.P. The uremic guanidino compounds guanidinosuccinic acid induces behavioral convulsions and concomitant epileptiform electrocorticographic discharges in mice. Brain Res. 598:1992;316-320.
15. R. D'Hooge, A. Raes, P. Lebrun, M. Diltoer, P.-P. van Bogaert, J. Manil, F. Colin, P.P de Deyn, Neural excitation by uremic guanidino compounds, in: P.P. de Deyn, I.A. Marescau, S.D. Qureshi, A. Mori (Eds.), Guanidino Compounds in Biology and Medicine, Vol. 2, John Libbey & Co., Guildford, UK, 1997, pp. 349-357.
16. Ericinska M., Silver I.A. Ions and energy in mammalian brain. Prog. Neurobiol. 43:1994;37-71.
17. + pump in epilepsy. Ann. Neurol. 16:1984;128-134. Suppl.
18. M. Hiramatsu, S. Ohba, R. Edamatsu, D. Kadowari, A. Mori, Effect of guanidino compounds on membrane fluidity of rat synaptosomes, in: P.P. de Deyn, I.A. Marescau, S.D. Quereshi, A. Mori (Eds.), Guanidino Compounds in Biology and Medicine, Vol. 1, John Libbey & Co., Guildford, UK, 1992, pp. 387-393.
19. Y. Hyrayasu, K. Morimoto, S. Otsuki, A. Mori, Increase of guanidinoacetic acid and methylguanidine in the brain following amygdala kindling in rats, in: P.P. de Deyn, B. Marescau, V., Stalon, I.A. Qureshi (Eds.), Guanidino Compounds in Biology and Medicine, John Libbey & Co., London, 1994, pp. 419-424.
20. Jones D.H., Matus A.I. Isolation of synaptic plasma membrane from brain by combination flotation-sedimentation density gradient centrifugation. Biochim. Biophys. Acta. 356:1974;276-287.
21. Lees G.J., Lehmann A., Sandberg M., Hamberg H. The neurotoxicity of ouabain, a sodium-potassium ATPase inhibitor, in the rat hippocampus. Neurosci. Lett. 120:1990;159-162.
22. Lees G.J. Contributory mechanisms in the causation of neurodegenative disorders. Neuroscience. 54:1993;287-322.
23. G.J. Lees, W. Leong, Brain lesions induced by specific and non-specific inhibitors of sodium-potassium ATPase, 649, 1995, pp. 225-233.
24. Marescau B., Qureshi I.A., de Deyn P.P., Letarte J., Ryba R., Lowenthal A. Guanidino compounds in plasma, urine and cerebrospinal fluid of hyperargininemic patients during therapy. Clin. Chim. Acta. 146:1985;21-27.
25. Marescau B., de Deyn P.P., Lowenthal A.et al. Guanidino compound analysis as a complementary diagnostic parameter for hyperargininemia: follow-up of guanidino compound levels during therapy. Pediatr. Res. 27:1990;297-303.
26. Marescau B., Deshmukh D.R., Kockx M., Possemiers I., Qureshi I.A., Wiechert P., de Deyn P.P. Guanidino compounds in serum, urine, liver, kidney and brain of man and some urotelic animals. Metabolism. 41:1992;526-532.
27. Matsumoto M., Kobayashi K., Kishikawa H., Mori A. Convulsive activity of methylguanidine in cat and rabbits. IRCS Med. Sci. 4:1976;65.
28. +-ATPase activity. J. Neurochem. 27:1976;635-636.
29. Matsumoto M., Fujiwara M., Mori A., Robin Y. Effet des dérivés guanidiques sur la cholinestérase et sur l'acétylcholinestérase du cerveau de lapin. Comp. Rend. Soc. Biol. 171:1977;1226-1229.
30. Menini T., Ceci A., Caccia S., Garattini S., Masturzo P., Salmona M. Diazepam increases membrane fluidity of rat hippocampus synaptosomes. FEBS Lett. 173:1984;255-258.
31. Mizutani N., Hayakawa C., Ohya Y., Watanabe K., Watanabe Y., Mori A. Guanidino compounds in hyperargininemia. J. Exp. Med. 153:1987;197-205.
32. Mori A., Ohkusu H. Isolation of α-N-acetyl-L-arginine from calf brain in convulsive seizures induced by this substance. Adv. Neurol. Sci. 15:1971;304-306.
33. Mori A. Biochemistry and neurotoxicity of guanidino compounds. History and recent advances. Pavlovian J. Biol. Sci. 22:1987;85-94.
34. Moryama T., Nakahama H., Dukuhara Y., Horio M., Yanase M., Orita Y., Kamada T., Kanashoro M., Miyake Y. Decrease in the fluidity of brush-border membrane vesicles induced by gentamicin. A spin labeling study. Biochem. Pharmacol. 38:1989;1169-1174.
35. Perlman B.J., Goldstein D.B. Membrane-disordering potency and anticonvulsant action of valproic acid and other short-chain fatty acids. Pharmacology. 26:1984;83-89.
36. Qureshi I.A., Letarte J., Quellet R., Larochelle J., Lemieux B. A new French-Canadian family affected by hyperargininemia. J. Inherited Metab. Dis. 6:1983;179-182.
37. +-ATPase in the brain. Epilepsy. 33:1992;58-64.
38. Satoh E., Nakazato Y. On the mechanism of ouabain-induced release of acetylcholine from synaptosomes. J. Neurochem. 58:1992;1038-1044.
39. Schreier S., Polnazek C.F., Smith I.C.P. Spin labels in membrane: problem in practice. Biochem. Biophys. Acta. 553:1978;84-95.
40. Shiraga H., Hiramatsu M., Mori A. Convulsive activity of α-guanidino glutaric acid and the possible involvement of 5-hydroxytryptamine in the α-guanidino glutaric acid induced seizure mechanism. J. Neurochem. 47:1986;1832-1836.
41. Snyderman S.E., Sansaricq C., Chen W.J., Norton P.M., Phansalkar S.V. Argininemia. J. Pediatr. 90:1977;563-568.
42. +)-stimulated ATPase in brain. J. Biol. Chem. 254:1979;6060-6067.
43. Terheggen H.G., Schwenk A., Lowenthal A., van Sandh M., Colombo J.P. Argininemia with arginase deficiency. Lancet. 2:1969;748.
44. Terheggen H.G., Lavinha F., Colombo J.P., van Sande M., Lowenthal A. Familial hyperargininemia. Arch. Dis. Child. 50:1975;57.
45. +)-stimulated ATPase and acetylcholinesterase activities of dog brain synaptosomal plasma membranes. Biochem. J. 22:1984;301-307.
46. Westerink B.H.C., Damsma G., Vries J.B. Effect of ouabain applied by intrastriatal microdialysis on the in vivo release of dopamine, acetylcholine, and amino acids in the brain of conscious rats. J. Neurochem. 52:1989;705-712.
47. Wheller K.P., Walker J.A., Barker D.M. Lipid requirement of the membrane sodium-plus-potassium ion-dependent adenosine triphosphatase system. Biochem. J. 146:1975;713-722.
48. Wierchert P., Marescau B., de Deyn P.P., Lowenthal A. Guanidino compounds in serum and brain of audiogenic sensitive rats during the preconvulsive running phase of cerebral seizures. Neuroscience. 13:1987;35-40.
49. +-ATPase activity in the synaptic plasma membrane from cerebral cortex of rats subjected to chemically induced phenylketonuria. Med. Sci. Res. 23:1995;261-262.
50. +-ATPase in synaptic plasma membranes from cerebral cortex of rats. Biochem. Soc. Trans. 23:1995;227s.
51. +-ATPase from rat brain cortex of rats by propionic acids. NeuroReport. 9:1998;1719-1721.
52. Yokoi I., Toma J., Mori A. The effect of homoarginine on the EEG of rats. Neurochem. Pathol. 2:1984;295-300.